Evidence map›Paper›PMID 34450104›Full record

ReviewThe Lancet. Haematology2021

Vaccine efficacy and iron deficiency: an intertwined pair?

Hal Drakesmith, Sant-Rayn Pasricha, Ioav Cabantchik, Chaim Hershko, Guenter Weiss, Domenico Girelli, Nicole Stoffel, Martina U Muckenthaler, Elizabeta Nemeth, Clara Camaschella and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in The Lancet. Haematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Review
  9. Iron and the immune system.Nature reviews. Immunology · 2025
    Review
  10. Article
  11. Iron Deficiency Anemia.Advances in experimental medicine and biology · 2025
    Review
  12. Iron, Hepcidin, and Immunity.Advances in experimental medicine and biology · 2025
    Review
  13. Article
  14. Why cells need iron: a compendium of iron utilisation.Trends in endocrinology and metabolism: TEM · 2024
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Hal DrakesmithMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK; Haematology Theme, Oxford Biomedical Research Centre, Oxford, UK. Electronic address: alexander.drakesmith@imm.ox.ac.uk.
Sant-Rayn PasrichaPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Diagnostic Haematology, The Royal Melbourne Hospital, Parkville, VIC, Australia; Clinical Haematology, The Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.
Ioav CabantchikInstitute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel.
Chaim HershkoInternal Medicine, Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.
Guenter WeissDepartment of Internal Medicine II, Infectious Diseases, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
Domenico GirelliDepartment of Medicine, Section of Internal Medicine, University of Verona, Verona, Italy.
Nicole StoffelDepartment of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
Martina U MuckenthalerDepartment of Pediatric Hematology, Oncology and Immunology, University of Heidelberg, Heidelberg, Germany; Molecular Medicine Partnership Unit, Heidelberg, Germany.
Elizabeta NemethCenter for Iron Disorders, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Clara CamaschellaDivision of Genetics and Cell Biology, San Raffaele Scientific Institute, Milano, Italy.
Paul KlenermanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
Michael B ZimmermannMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
Hebrew University of Jerusalem · ILETH Zurich · CHHeidelberg University · DEInnsbruck Medical University · ATUniversity of Verona · IT

Funding

Iron physiology and pathology in pregnancyR01HD096863 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEMETH, ELIZABETA · 2019 to 2023
$2.1M
Adverse Interaction Between Iron Deficiency and Inflammation in PregnancyR21HD104014 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEMETH, ELIZABETA · 2021 to 2022
$429k
NICHD NIH HHS R01 HD096863NICHD NIH HHS R21 HD104014Wellcome Trust 109965/Z/15/Z
6 · The paper itself

Abstract

Vaccines are the most effective measure to prevent deaths and illness from infectious diseases. Nevertheless, the efficacy of several paediatric vaccines is lower in low-income and middle-income countries (LMICs), where mortality from vaccine-preventable infections remains high. Vaccine efficacy can also be decreased in adults in the context of some common comorbidities. Identifying and correcting the specific causes of impaired vaccine efficacy is of substantial value to global health. Iron deficiency is the most common micronutrient deficiency worldwide, affecting more than 2 billion people, and its prevalence in LMICs could increase as food security is threatened by the COVID-19 pandemic. In this Viewpoint, we highlight evidence showing that iron deficiency limits adaptive immunity and responses to vaccines, representing an under-appreciated additional disadvantage to iron deficient populations. We propose a framework for urgent detailed studies of iron-vaccine interactions to investigate and clarify the issue. This framework includes retrospective analysis of newly available datasets derived from trials of COVID-19 and other vaccines, and prospective testing of whether nutritional iron interventions, commonly used worldwide to combat anaemia, improve vaccine performance.

Indexed as

Adaptive ImmunityAnemia, Iron-DeficiencyCOVID-19COVID-19 VaccinesDeveloping CountriesHumansPandemicsRetrospective StudiesSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID34450104
PMCPMC8384343
OpenAlexW3194360510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.